Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis

• Status: Unknown status
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

We hypothesise that the use of Adelmidrol (Saginil in vaginal cannulas) can reduce the incidence and magnitude of vaginitis in patients affected by gynecologic malignancies.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Università degli Studi dell'Insubria

Criteria

Inclusion Criteria:

• Gynecologic malignancy

• Current administration of chemotherapy

Exclusion Criteria:

• Colpectomy

• Vaginal cancer

• Vulvar cancer

• Bacterial vaginitis